M&A Deal Summary

Tilray Acquires Alef Biotechnology

On October 9, 2018, Tilray acquired life science company Alef Biotechnology for 5M CAD

Acquisition Highlights
  • This is Tilray’s 1st transaction in the Life Science sector.
  • This is Tilray’s 2nd largest (disclosed) transaction.
  • This is Tilray’s 1st transaction in Chile.

M&A Deal Summary

Date 2018-10-09
Target Alef Biotechnology
Sector Life Science
Buyer(s) Tilray
Deal Type Add-on Acquisition
Deal Value 5M CAD

Target

Alef Biotechnology

Santiago, Chile
Alef Biotechnology SpA is focused on medical cannabis research and development for the treatment of various medical conditions. Its purpose is to increase the quality of life of those in pain, bringing dignity by developing innovative drugs and novel drug delivery systems to the market.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tilray

Leamington, Ontario, Canada

Category Company
Sector Healthcare Services
Employees1,600
Revenue 821M USD (2025)
DESCRIPTION

Tilray is a medical cannabis company, involved in cultivating and delivering the medical benefits of cannabis safely and reliably. Tilray is based in Leamington, Ontario.


DEAL STATS #
Overall 1 of 5
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 5
Country: Chile M&A 1 of 1
Year: 2018 M&A 1 of 1
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-19 Natura Naturals Holdings

Leamington, Ontario, Canada

Natura Naturals Holdings, Inc. is a licensed cultivator of cannabis in accordance with the Cannabis Act and Cannabis Regulations. The company's cultivation facility is capable of producing plants in a 662,000 square-foot greenhouse facility, of which 155,000 is currently licensed, under optimal growing conditions. Natura Naturals Holdings is based in Leamington, Ontario.

Buy -